scholarly article | Q13442814 |
P50 | author | Anke van den Berg | Q37375568 |
Lu Ping Tan | Q39889837 | ||
P2093 | author name string | Bart-Jan Kroesen | |
Johan H Gibcus | |||
Peter Möller | |||
Sibrand Poppema | |||
Tjasso Blokzijl | |||
Debora de Jong | |||
Geert Harms | |||
Rikst Nynke Schakel | |||
P2860 | cites work | Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 |
miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 | ||
MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 | ||
The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding | Q24644692 | ||
MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways | Q24650451 | ||
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. | Q46986151 | ||
Computational methods for microRNA target prediction. | Q51907240 | ||
Teashirt 3 expression in the chick embryo reveals a remarkable association with tendon development. | Q52019954 | ||
Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome. | Q53275615 | ||
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. | Q53931762 | ||
Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma. | Q54780875 | ||
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia | Q57234164 | ||
Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma | Q57374943 | ||
The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a | Q64462273 | ||
Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implications | Q69808243 | ||
A viral microRNA functions as an orthologue of cellular miR-155 | Q24652947 | ||
MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase | Q24653222 | ||
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development | Q24674155 | ||
Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas | Q24675877 | ||
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans | Q27861103 | ||
MicroRNA expression profiles classify human cancers | Q28032481 | ||
Molecular evolution of a microRNA cluster | Q28261071 | ||
Regulation of the germinal center response by microRNA-155 | Q29547777 | ||
miR-21-mediated tumor growth | Q29616149 | ||
microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells | Q29619307 | ||
MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb | Q29619411 | ||
Genesis: cluster analysis of microarray data | Q29619630 | ||
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock | Q29619768 | ||
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas | Q29622911 | ||
Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma | Q33260709 | ||
Hodgkin's disease: classification and differential diagnosis | Q33539875 | ||
Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. | Q34460936 | ||
MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts | Q34521975 | ||
Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma | Q34528341 | ||
miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression | Q34762601 | ||
Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia | Q35022890 | ||
miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely | Q35758613 | ||
The role of microRNAs in normal hematopoiesis and hematopoietic malignancies | Q36600938 | ||
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas | Q36734930 | ||
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma | Q40016162 | ||
MicroRNA expression profiling in classic Hodgkin lymphoma | Q40033467 | ||
Downregulation of microRNAs-143 and -145 in B-cell malignancies | Q40076849 | ||
Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon | Q40247827 | ||
BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV. | Q40274085 | ||
Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma | Q40330082 | ||
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma | Q40679662 | ||
Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient. | Q41206007 | ||
Direct and sensitive miRNA profiling from low-input total RNA. | Q41500041 | ||
Two neoplastic cell lines with unique features derived from Hodgkin's disease | Q42801626 | ||
Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines | Q45423789 | ||
Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas | Q45424270 | ||
Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cells | Q45877769 | ||
P433 | issue | 2 | |
P921 | main subject | Hodgkin lymphoma | Q209369 |
microRNA expression | Q60681249 | ||
P304 | page(s) | 167-176 | |
P577 | publication date | 2009-02-01 | |
P1433 | published in | Neoplasia | Q2962042 |
P1476 | title | Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile | |
P478 | volume | 11 |
Q60045684 | A heterogeneous label propagation approach to explore the potential associations between miRNA and disease |
Q38350728 | A high throughput experimental approach to identify miRNA targets in human cells. |
Q27349177 | A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia |
Q93059705 | Analyzing the regulation of miRNAs on protein-protein interaction network in Hodgkin lymphoma |
Q38721982 | Argonaute 2 immunoprecipitation revealed large tumor suppressor kinase 1 as a novel proapoptotic target of miR-21 in T cells |
Q36555745 | CD46 Activation Regulates miR-150-Mediated Control of GLUT1 Expression and Cytokine Secretion in Human CD4+ T Cells |
Q39454046 | CD99 triggers upregulation of miR-9-modulated PRDM1/BLIMP1 in Hodgkin/Reed-Sternberg cells and induces redifferentiation |
Q38570169 | Cancer hallmarks in induced pluripotent cells: new insights |
Q36316601 | Cell-free Circulating miRNA Biomarkers in Cancer |
Q35000982 | Cellular localization and processing of primary transcripts of exonic microRNAs. |
Q37141244 | Cerebrospinal fluid miRNA profile in HIV-encephalitis. |
Q38251994 | Challenges and opportunities of microRNAs in lymphomas. |
Q38068839 | Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma |
Q21245705 | Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases |
Q35156115 | Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma |
Q39660739 | Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. |
Q36594081 | Defining Plasma MicroRNAs Associated With Cognitive Impairment In HIV-Infected Patients |
Q24628746 | Dinosaurs and ancient civilizations: reflections on the treatment of cancer |
Q34300594 | Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits |
Q39085506 | Dual role of miR-21 in CD4+ T-cells: activation-induced miR-21 supports survival of memory T-cells and regulates CCR7 expression in naive T-cells |
Q88917792 | Efficient and accurate analysis of microRNA using a specific extension sequence |
Q38920243 | Epigenetic regulation of microRNA expression in Hodgkin lymphoma. |
Q37786570 | Expression of miRNAs in Lymphocytes: A Review |
Q34664043 | Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation |
Q42165154 | Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP. |
Q34643277 | Hodgkin lymphoma |
Q36684218 | Illumina microRNA profiles reveal the involvement of miR397a in Citrus adaptation to long-term boron toxicity via modulating secondary cell-wall biosynthesis |
Q37393972 | Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice |
Q38825359 | Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma |
Q61807715 | Integrating random walk and binary regression to identify novel miRNA-disease association |
Q55500631 | Involvement of MicroRNAs in the Aging-Related Decline of CD28 Expression by Human T Cells. |
Q34646522 | Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation |
Q39467028 | MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma |
Q37045562 | MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1. |
Q28472349 | MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism |
Q34738140 | MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients |
Q58753107 | MiRNA Dysregulation in Childhood Hematological Cancer |
Q40867466 | Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables |
Q42703031 | Micro-RNA Expression and Function in Lymphomas |
Q39580400 | MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts. |
Q37623563 | MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma |
Q38860599 | MicroRNA-24 inhibits growth, induces apoptosis, and reverses radioresistance in laryngeal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein. |
Q41223735 | MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis. |
Q36602853 | MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies |
Q36335261 | MicroRNAs as Biomarkers in Cancer |
Q57814100 | MicroRNAs as Biomarkers of B-cell Lymphoma |
Q26862811 | MicroRNAs in B cell development and malignancy |
Q26824682 | MicroRNAs in B-cells: from normal differentiation to treatment of malignancies |
Q33877654 | MicroRNAs of the immune system: roles in inflammation and cancer |
Q93541677 | MicroRNAs: tiny players with a big role in the pathogenesis of leukemias and lymphomas |
Q39336949 | Non-Coding RNAs in Hodgkin Lymphoma |
Q41495243 | Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas. |
Q47114178 | PRMDA: personalized recommendation-based MiRNA-disease association prediction |
Q90387800 | Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors |
Q37417538 | Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. |
Q21134925 | Rapid generation of microRNA sponges for microRNA inhibition |
Q34557179 | Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies |
Q42314673 | Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas |
Q38222875 | Relevance of miR-21 in HIV and non-HIV-related lymphomas. |
Q90308213 | Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21 |
Q38095676 | Role of microRNA in the pathogenesis of malignant lymphoma. |
Q37868870 | Role of microRNAs in lymphoid biology and disease |
Q33684046 | Sequencing bias: comparison of different protocols of microRNA library construction |
Q26825764 | Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy |
Q37478602 | The War on Cancer rages on. |
Q39257795 | The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney. |
Q35669733 | The interconnectedness of cancer cell signaling |
Q35585502 | The relevance of miRNA-21 in HSV-induced inflammation in a mouse model |
Q38129726 | The role of miR-150 in normal and malignant hematopoiesis |
Q35885964 | Transcriptome dynamics of the microRNA inhibition response |
Q38145508 | Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer. |
Q36583369 | WBSMDA: Within and Between Score for MiRNA-Disease Association prediction |
Q38771877 | miR clusters target cellular functional complexes by defining their degree of regulatory freedom |
Q98386299 | microRNA-21 regulates the proliferation of placental cells via FOXM1 in preeclampsia |
Q37642868 | microRNAs in inflammation |
Q50544689 | microRNAs: Key Players in Hematopoiesis. |
Search more.